U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Elevated circulating fumarate concentration

MedGen UID:
1783022
Concept ID:
C5539652
Finding
HPO: HP:0033504

Definition

An increased concentration of fumarate, an intermediate in the citric acid cycle, in the blood circulation. [from HPO]

Term Hierarchy

Conditions with this feature

Mitochondrial complex III deficiency nuclear type 5
MedGen UID:
767522
Concept ID:
C3554608
Disease or Syndrome
Mitochondrial complex III deficiency is a genetic condition that can affect several parts of the body, including the brain, kidneys, liver, heart, and the muscles used for movement (skeletal muscles). Signs and symptoms of mitochondrial complex III deficiency usually begin in infancy but can appear later.\n\nThe severity of mitochondrial complex III deficiency varies widely among affected individuals. People who are mildly affected tend to have muscle weakness (myopathy) and extreme tiredness (fatigue), particularly during exercise (exercise intolerance). More severely affected individuals have problems with multiple body systems, such as liver disease that can lead to liver failure, kidney abnormalities (tubulopathy), and brain dysfunction (encephalopathy). Encephalopathy can cause delayed development of mental and motor skills (psychomotor delay), movement problems, weak muscle tone (hypotonia), and difficulty with communication. Some affected individuals have a form of heart disease called cardiomyopathy, which can lead to heart failure. \n\nMost people with mitochondrial complex III deficiency have a buildup of a chemical called lactic acid in the body (lactic acidosis). Some affected individuals also have buildup of molecules called ketones (ketoacidosis) or high blood glucose levels (hyperglycemia). Abnormally high levels of these chemicals in the body can be life-threatening.\n\nMitochondrial complex III deficiency can be fatal in childhood, although individuals with mild signs and symptoms can survive into adolescence or adulthood.

Recent clinical studies

Etiology

Wan Y, Yuan J, Li J, Li H, Yin K, Wang F, Li D
Clin Nutr 2020 Oct;39(10):3189-3198. Epub 2020 Feb 15 doi: 10.1016/j.clnu.2020.02.014. PMID: 32164980
Udell JA, Morrow DA, Braunwald E, Swedberg K, Bode C, Rifai N, Brunel PC, Prescott MF, Ren F, Hoffman EB, Scirica BM
Clin Chem 2013 Jun;59(6):959-67. Epub 2013 Mar 18 doi: 10.1373/clinchem.2012.199729. PMID: 23509108

Therapy

Wan Y, Yuan J, Li J, Li H, Yin K, Wang F, Li D
Clin Nutr 2020 Oct;39(10):3189-3198. Epub 2020 Feb 15 doi: 10.1016/j.clnu.2020.02.014. PMID: 32164980
Udell JA, Morrow DA, Braunwald E, Swedberg K, Bode C, Rifai N, Brunel PC, Prescott MF, Ren F, Hoffman EB, Scirica BM
Clin Chem 2013 Jun;59(6):959-67. Epub 2013 Mar 18 doi: 10.1373/clinchem.2012.199729. PMID: 23509108

Clinical prediction guides

Wan Y, Yuan J, Li J, Li H, Yin K, Wang F, Li D
Clin Nutr 2020 Oct;39(10):3189-3198. Epub 2020 Feb 15 doi: 10.1016/j.clnu.2020.02.014. PMID: 32164980
Udell JA, Morrow DA, Braunwald E, Swedberg K, Bode C, Rifai N, Brunel PC, Prescott MF, Ren F, Hoffman EB, Scirica BM
Clin Chem 2013 Jun;59(6):959-67. Epub 2013 Mar 18 doi: 10.1373/clinchem.2012.199729. PMID: 23509108

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...